SCHEMBL19236962

SCHEMBL19236962

CCCCOC(=O)Cn1nc(C#N)c2ccc(O)cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.41
▸ KMT2A Q03164 5/20 0.41
▸ ESR1 P03372 4/20 0.41
▸ MAPT P10636 3/20 0.40
▸ POLB P06746 1/20 0.40
▸ CNR1 P21554 1/20 0.40
▸ LMNA P02545 2/20 0.38
▸ TSHR P16473 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ NR1H2 P55055 1/20 0.38
▸ RNASEL Q05823 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ L3MBTL1 Q9Y468 3/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ GAA P10253 2/20 0.36
▸ MIF P14174 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24920127 0.84 KDM4E (0.43) MEN1KMT2AESR1MAPTPOLB
SCHEMBL19236960 0.83 MEN1 (0.46) MEN1KMT2AESR1MAPTPOLB
SCHEMBL19236791 0.81 MEN1 (0.42) MEN1KMT2AESR1MAPTPOLB
SCHEMBL17026631 0.81 ESR1 (0.36) KMT2AESR1LMNASMN1; SMN2ALDH1A1
SCHEMBL17026547 0.79 ELANE (0.42) MEN1KMT2AESR1MAPTLMNA
SCHEMBL19236963 0.72 PSEN1 (0.42) MEN1KMT2AMAPTPOLBCNR1
SCHEMBL17026619 0.69 HSD17B10 (0.43) ESR1LMNAMAPK1ALDH1A1
SCHEMBL18610932 0.67 MEN1 (0.42) MEN1KMT2AMAPTPOLBCNR1
SCHEMBL29358588 0.67 MEN1 (0.41) MEN1KMT2AMAPTPOLBCNR1
SCHEMBL19208089 0.67 BRD4 (0.37) KMT2APOLBLMNACYP2C19SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230218578-A1 BENZOPYRAZOLE COMPOUNDS AND ANALOGUES THEREOF WILMINGTON TRUST, NATIONAL ASSOCIATION 2023-07-13 — — US disclosed
WO-2017136395-A1 BENZOPYRAZOLE COMPOUNDS AND ANALOGUES THEREOF BIOCRYST PHARMACEUTICALS, INC. (US) 2017-08-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230218578-A1 BENZOPYRAZOLE COMPOUNDS AND ANALOGUES THEREOF C9, C5, C1QBP MEN1 1283/4885KMT2A 4751/4885ESR1 3563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback